Patents by Inventor Winnie Tam

Winnie Tam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230321097
    Abstract: The present invention relates to, inter alia, combinations, methods, compositions, and oral dosage forms of a FAK inhibitor and a MEK inhibitor, for treating abnormal cell growth (e.g., cancer).
    Type: Application
    Filed: November 17, 2022
    Publication date: October 12, 2023
    Inventors: Jonathan A. Pachter, Winnie Tam, Qunli Xu
  • Publication number: 20200147080
    Abstract: The present invention relates to, inter alia, combinations, methods, compositions, and oral dosage forms of a FAK inhibitor and a MEK inhibitor, for treating abnormal cell growth (e.g., cancer).
    Type: Application
    Filed: July 23, 2019
    Publication date: May 14, 2020
    Inventors: Jonathan A. Pachter, Winnie Tam, Qunli Xu
  • Patent number: 10406158
    Abstract: The present invention relates to, inter alia, combinations, methods, compositions, and oral dosage forms of a FAK inhibitor and a MEK inhibitor, for treating abnormal cell growth (e.g., cancer).
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: September 10, 2019
    Assignee: Verastem, Inc.
    Inventors: Jonathan A. Pachter, Winnie Tam, Qunli Xu
  • Publication number: 20190046531
    Abstract: The present invention relates to, inter alia, combinations, methods, compositions, and oral dosage forms of a FAK inhibitor and a MEK inhibitor, for treating abnormal cell growth (e.g., cancer).
    Type: Application
    Filed: April 2, 2018
    Publication date: February 14, 2019
    Inventors: Jonathan A. Pachter, Winnie Tam, Qunli Xu
  • Patent number: 9962385
    Abstract: The present invention relates to, inter alia, combinations, methods, compositions, and oral dosage forms of a FAK inhibitor and a MEK inhibitor, for treating abnormal cell growth (e.g., cancer).
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: May 8, 2018
    Assignee: Verastem, Inc.
    Inventors: Jonathan A. Pachter, Winnie Tam, Qunli Xu
  • Publication number: 20160346282
    Abstract: The present invention relates to, inter alia, combinations, methods, compositions, and oral dosage forms of a FAK inhibitor and a MEK inhibitor, for treating abnormal cell growth (e.g., cancer).
    Type: Application
    Filed: February 6, 2015
    Publication date: December 1, 2016
    Inventors: Jonathan A. Pachter, Winnie Tam, Qunli Xu